Preoperative Cannabis Abstinence Guidelines (.5 Class A CE with .5 Pharm)
Monday, September 24
10:30 AM - 11:00 AM
Location: Room 312, Hynes
In an effort to provide the safest and best care for patients, providers must weigh the potential harm with the potential benefit for cannabis abstinence. Patients who use cannabis to control other symptoms may face a return of symptoms following a abrupt cannabis cessation. Chronic users may suffer withdrawal symptoms that complicate their perioperative course. Continuation of cannabis therapy regime, except edible preparations, in the preoperative period should be encouraged in the chronic and medical user. Attendees will be given evidence based guidelines to inform anesthetic planning.
- Explain current understanding of cannabis pharmacokinetics, pharmacodynamics, especially in reference to anesthesia and perioperative course,
- Evaluate the risks of cannabis abstinence for the chronic user.
- Discuss potential perioperative complications for the cannabis user, as a result of either abstinence or non-abstinence.